Leanne de Koning - Concepedia

Author

Leanne de Koning

Also Known As

Koning, Leanne, L De Koning, L de Koning, L. De Koning, L. de Koning, Leanne De Koning, Leanne De koning, Leanne de Koning, Sergio Roman Roman, de Koning, Leanne

173

Publications

3.8K

Citations

H-Index

Concepts

All Affiliations

Institut Curie Inserm Université Paris Sciences et Lettres Centre National de la Recherche Scientifique Université Paris Cité

About

Leanne de Koning is an author at Institut Curie specializing in medicine, tumor biology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	18	1.1K
2	Health Sciences	6	6	163
3	Natural Sciences	4	4	286
4	Biochemistry	2	2	77
5	Applied Physiology	1	1	10

Leanne de Koning

Publications

3.3K

Citations

H-Index

Page 1

	Year	Citations
Dissecting heterogeneity in malignant pleural mesothelioma through histo-molecular gradients for clinical applications Yuna Blum, Clément Meiller, Lisa Quetel, Nature Communications	2019	197
Polo-like Kinase 1: A Potential Therapeutic Option in Combination with Conventional Chemotherapy for the Management of Patients with Triple-Negative Breast Cancer Virginie Maire, Fariba Némati, Marion Richardson, Cancer Research Breast OncologyTnbc Cell LinesPathologyCell DeathCancer Biology	2012	188
Asf1b, the necessary Asf1 isoform for proliferation, is predictive of outcome in breast cancer Armelle Corpet, Leanne de Koning, Joern Toedling, The EMBO Journal Tumor BiologyBreast OncologyOncologyEndocrine-related CancerMedicine	2010	180
Integration of genomic, transcriptomic and proteomic data identifies two biologically distinct subtypes of invasive lobular breast cancer Magali Michaut, Suet‐Feung Chin, Ian J. Majewski, Scientific Reports	2016	173
Analysis of Liver Cancer Cell Lines Identifies Agents With Likely Efficacy Against Hepatocellular Carcinoma and Markers of Response Stefano Caruso, Anna-Line Calatayud, Jill Pilet, Gastroenterology	2019	171
Realizing the Promise of Reverse Phase Protein Arrays for Clinical, Translational, and Basic Research: A Workshop Report Rehan Akbani, Karl‐Friedrich Becker, Neil O. Carragher, Molecular & Cellular Proteomics Immunocytochemical TechniqueProtein AssemblyBasic ResearchImmunologyMolecular Biology	2014	169
TTK/hMPS1 Is an Attractive Therapeutic Target for Triple-Negative Breast Cancer Virginie Maire, Céline Baldeyron, Marion Richardson, PLoS ONE Breast OncologyMedicinePathologyCell DeathCancer Genomics	2013	166
PI3K/AKT pathway activation in bladder carcinogenesis Julien Caldéraro, Sandra Rebouissou, Leanne de Koning, International Journal of Cancer	2013	95
Prognostic value of a newly identified MALAT1 alternatively spliced transcript in breast cancer Didier Meseure, Sophie Vacher, François Lallemand, British Journal of Cancer	2016	91
Consensus on precision medicine for metastatic cancers: a report from the MAP conference Charles Swanton, J.C. Soria, Alberto Bardelli, Annals of Oncology UrologyMap ConferenceMedicinePrecision MedicineMetastatic Cancers	2016	90

Page 1